Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Use of bifidobacterium cell wall and bifidobacterium cell wall protein in pharmacy

A technology of bifidobacteria cells and proteins is applied in the pharmaceutical field to achieve the effects of effective growth advantages, wide sources and simple preparation methods

Inactive Publication Date: 2005-01-12
SICHUAN UNIV
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Studies have shown that it has an important impact on the body's immune system, especially the activation of the body's immune system, for example, activation of macrophages, B lymphocytes, NK cells, ... (see "Immune activation of bifidobacteria and their biological Scientific Significance”, Wang Lisheng Review, Pan Lingjia Zhou Dianyuan Review, Foreign Medical Physiology, Pathology and Clinical Volume, 1998.18(4), P 320-322 ), but there is no report on the activation of defensins by bifidobacteria cell walls and cell wall proteins

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of bifidobacterium cell wall and bifidobacterium cell wall protein in pharmacy
  • Use of bifidobacterium cell wall and bifidobacterium cell wall protein in pharmacy
  • Use of bifidobacterium cell wall and bifidobacterium cell wall protein in pharmacy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0023] 1. Cell lines and bacterial strains

[0024] The human intestinal glandular epithelial cell line HT-29 is derived from ATCC and preserved by the applicant’s laboratory of infection and immunity. Laboratory culture, and by the National Institute of Pharmaceutical and Biological Products and the Institute of Epidemiology and Microbiology, Chinese Academy of Preventive Sciences identified. Inoculate in MRS medium and culture anaerobically at 37°C for 48 hours.

[0025] Prepare MRS medium (1 liter):

[0026] Peptone 10g, yeast powder 5g, tryptone 3g, glucose 10g, soluble starch 0.5g, ferrous sulfate 100mg, manganese sulfate 6.74mg, magnesium sulfate 200mg, cysteine ​​0.5g, potassium dihydrogen phosphate 1g, hydrogen phosphate Dipotassium 1g, sodium chloride 100mg, sodium acetate 5g, trisodium citrate 2g, Tween-80 1.0g, add distilled water to 1 liter, adjust pH to 7.2, high temperature, high pressure, sterilization.

[0027] 2. Reagents

[0028]Agarose, two-step RT-PCR k...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The present invention utilizes the tests to show that the bifidobacterium cell wall and cell wall protein area effective factor for activating phylaxin gene, can obviously raised the expression of the phylaxin, so that the bifidobacterium cell wall and cell wall protein can be used for preparing the medicine for activating the phylaxin gene of mammals. Its medication method can utilize per os, intraveously (IV), inhalation or suppository, enteroclyster or oral irrigation. According to the characteristics of phylaxin of human body said invented medicine mainly is used for immunotherapy of infective diseases of digestive tract, respiratory tract and urinogenital tract, etc.

Description

1. Technical field [0001] The present invention relates to the use of bifidobacterium cell wall and bifidobacterium cell wall protein, especially in the field of pharmacy. 2. Background technology [0002] Bifidobacterium is one of the earliest physiological bacteria discovered, and has been clinically applied in the prevention and treatment of intestinal diseases and the treatment of liver diseases (see "Bifidobacteria" p 131-139 , edited by Kang Bai, Dalian Maritime University Press, May 1998). Studies have shown that it has an important impact on the body's immune system, especially the activation of the body's immune system, for example, activation of macrophages, B lymphocytes, NK cells, ... (see "Immune activation of bifidobacteria and their biological Scientific Significance”, Wang Lisheng Review, Pan Lingjia Zhou Dianyuan Review, Foreign Medical Physiology, Pathology and Clinical Volume, 1998.18(4), P 320-322 ), but there is no report on the bifidobacteria cell wal...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/16A61P31/00A61P37/02
Inventor 王伯瑶王国兴黄宁吴琦汪宇辉冯云
Owner SICHUAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com